Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index; none of the 132 sources its claims cite is checked for support yet.
Abstract
The global prevalence of early-onset type 2 diabetes (EOT2D) is rising rapidly. Adults with EOT2D represent a high-risk population characterised by increased rates of microvascular and macrovascular complications, adverse psychological wellbeing and psychiatric comorbidities such as depression, and premature mortality compared to those with later-onset type 2 diabetes mellitus. This emerging population faces unique challenges, including high levels of diabetes-related stigma, clinical inertia, and competing life demands, such as starting a family. This review synthesises current evidence on the clinical management of EOT2D. Key therapeutic targets include weight reduction, preservation of β-cell function, cardiometabolic risk management, and psychological support. Overall, there are few randomized controlled trials (RCTs) undertaken specifically in adults with EOT2D. However, we summarise early data from the few RCTs that do report outcomes specific in young adults, with bariatric surgery, tirzepatide and intensive lifestyle interventions emerging as particularly effective treatments. There is a strong rationale that technology-based inventions and structured education programs may prove to be effective treatments but data from RCTs is lacking. We provide broad recommendations for future research and clinical practice based on the current evidence. In conclusion, substantial further research is required to inform tailored, evidence-based guidelines and improve long-term outcomes in this underserved population.
Overview
CoChat Summary
TL;DR
This narrative review summarizes current evidence on managing early-onset type 2 diabetes (EOT2D; diagnosis <40 years) in adults, a high-risk group with more complications, mental-health burden, and premature mortality than later-onset T2DM. It finds the strongest RCT/subanalysis signals for tirzepatide, bariatric surgery, and intensive lifestyle intervention, but concludes dedicated trials and tailored guidelines are urgently needed.
Key findings
- EOT2D accounts for 15% to 20% of adults diagnosed with T2DM worldwide and is associated with higher microvascular and macrovascular disease, mortality, and psychological burden; 50% of adults with EOT2D report moderate-to-high diabetes distress versus 19% among those diagnosed with T2DM aged ≥60 years.
- In the VERIFY subanalysis, adults with EOT2D (n=186; 9.3%) versus later-onset T2DM (n=1,815; 90.7%) had 5-year treatment failure (HbA1c ≥7.0%) of 50.5% with metformin plus vildagliptin versus 73.3% with metformin monotherapy in EOT2D; later-onset rates were 42.9% versus 61.0%. In the SURPASS post hoc analysis, SURPASS-2 included ~22.0% EOT2D (n=1,878); at 40 weeks, tirzepatide 15 mg reduced HbA1c by –2.6% versus –1.9% with semaglutide 1 mg, with 93.5% versus 75.3% achieving HbA1c <7.0%, and greater weight reduction (–14.0% vs. –5.4%).
- Bariatric surgery observational data showed higher T2DM remission in EOT2D than later-onset T2DM at 1 year (56.9% vs. 50.2%) and 5 years (65.3% vs. 54.2%), plus greater 5-year weight loss (30.4% vs. 21.6%). The DIADEM-I intensive lifestyle RCT reported 12-month weight loss of –12.0 kg versus –4.0 kg with standard care and diabetes remission of 61.4% versus 11.6%; DiRECT remission fell from 46% at 1 year to 12.9% at 5 years (7% by intention-to-treat).
- A CGM umbrella review found an HbA1c mean difference of –0.40% (95% CI, –0.54 to –0.25) in T2DM; one internet-based DSMES RCT in Chinese young adults (n=60 per group) showed greater 12-month HbA1c reduction (–1.8% vs. –1.2%, P<0.001) and remission (60% vs. 37%, P=0.03), but no RCTs specifically evaluated CGM, insulin pumps, or closed-loop therapy in adults with EOT2D.
Methods
- Design: narrative review synthesizing current evidence on clinical management of EOT2D in adults; children and pregnancy management were excluded from scope.
- Data/sample: cites RCTs, RCT subanalyses/post hoc analyses, observational studies, and systematic/umbrella reviews; no primary data collection. Dedicated EOT2D RCT evidence is limited to a few trials/subanalyses, including VERIFY, SURPASS, DIADEM-I, a small CGM-guided pilot, and an internet-based DSMES trial.
- Main analysis: narrative synthesis and broad recommendations for practice and future research; no systematic search strategy, meta-analysis, or formal risk-of-bias assessment is described.
Limitations
- Stated: few RCTs have been undertaken specifically in adults with EOT2D; young adults aged 18 to 39 years represent <5% of participants in prominent clinical trials; no specific clinical guidelines exist; long-term and hard clinical outcome data are lacking; the internet-based DSMES trial’s generalisability is limited to Chinese young adults, and sustainability questions remain.
- Evident: as a narrative review, it does not report a systematic search, inclusion criteria, or quality appraisal, so selection and synthesis may be non-exhaustive.
- Evident: many conclusions rely on subanalyses, post hoc analyses, or observational data rather than dedicated RCTs in EOT2D, and the authors avoid specific combination-therapy recommendations because direct comparisons are limited.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 6 Not valid · 74 Not checked · 33 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is therefore unsurprising that there are no specific clinical guidelines for the management of EOT2D.”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTRODUCTION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To date, only one RCT has assessed the impact of an intensive lifestyle intervention on diabetes-related outcomes in adults with EOT2D.”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Lifestyle interventions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Currently, only two RCTs have reported data surrounding the effectiveness of pharmacological treatment in adults with EOT2D in sub-analyses of larger RCTs [65,66].”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Pharmacological interventions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, there remains a dearth of studies investigating the impact of lifestyle interventions in adults with EOT2D [22].”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Lifestyle interventions
What the sources say
- Not checked yetcites [22] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Moreover, people with EOT2D remain underrepresented in research focused on DSMES [22].”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Diabetes self-management education and support
What the sources say
- Not checked yetcites [22] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 113 claims and to verify the 124 references still open.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 14
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent recommendations for the management of EOT2D have highlighted the importance of mental well‐being, identifying it as an essential component of care and a key treatment target.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“In addition to physical complications, existing evidence suggests that EOT2D is associated with unique psychosocial challenges and an increased risk of mental health comorbidities (the presence of two or more conditions), such as anxiety, depression and diabetes‐related distress.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“Young adults may now represent 15%–20% of all adults diagnosed with T2D globally.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“This is of great importance given the increased risk of EOT2D among individuals of non‐White ethnicity.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“In a population facing long disease duration and elevated lifetime risk of cardio-renal events, such continuous, context-rich monitoring offers a plausible pathway to better cardiometabolic risk factor control and clinical outcomes, although head-to-head comparisons of CGM efficacy and hard endpoints (hospitalization, cardiovascular and kidney events, mortality) between people with EOT2D and usual”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [28]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Claggett, B., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206286 · Cited by 2,884
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104 · cited 3×
“Indeed, intensive interventions incorporating very-low energy diets and increased physical activity have been increasingly recognised as effective methods of improving T2DM management in adults and children [74].”
InfluentialSelf-citationU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
Mechanism linking diabetes mellitus and obesity
Algoblan, A., Alalfi, M., & Khan, M. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s67400 · Cited by 1,028
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
Chrvala, C. A., Sherr, D., & Lipman, R. D. (2016) · Patient Education and Counseling · doi:10.1016/j.pec.2015.11.003 · Cited by 914
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 878
Research works printed but not linked: 8
- IDF Diabetes Atlas 2021
- National diabetes statistics report
- Care processes and treatment targets
- 10.2337/figshare.13373708 · DOI · Paper page
- Arnett, 2019, 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines, e563
- Type 1 diabetes in adults: diagnosis and management
- Type 2 diabetes in adults
- NHS Long Term Plan: Diabetes
Cited by
Kim, Y., Ha, J., & Moon, J. S. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2026.0034 · Cited by 8
Caba, M., Carvalho, M., Forbes, A., Forde, R., Gill, K., Khalifa, M., Parsons, J., Speight, J., Trief, P. M., & Hadjiconstantinou, M. (2026) · Diabetic Medicine · doi:10.1111/dme.70352 · Cited by 2
Wei, X., 梁宝兰, & Chen, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1778646 · Cited by 2
Li, J., Tang, G., Xie, Z., Yang, L., Zhou, Z., & Guo, K. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113101 · Cited by 1
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J.
- Affiliations
- University of Leicester (GB)
- University of Nottingham (GB)
- Corresponding author
- Davies, Melanie J.
- ORCID
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2025-09-01
- Volume
- 49
- Issue
- 5
- Pages
- 934-950
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- PMC
- PMC12436035
- OpenAlex
- W4414002032
- Semantic Scholar
- 83dd4a6029da4725478e4ba21e81cb1d81c081bb
- Cited by
- 11
- References
- 115
- Citations by year
- 2026: 10 · 2025: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Diabetes & Metabolism Journal (publishedVersion, cc-by-nc)
- Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute for Health and Care Research (NIHR201165)
- NIHR Leicester Biomedical Research Centre
- Applied Research Collaboration East Midlands
- Welcome Trust Leicestershire Healthcare Inequalities Improvement Doctoral Training Programme (223512/Z/21/Z)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- early-onset type 2 diabetes, young adults, diabetes management, bariatric surgery, tirzepatide, intensive lifestyle intervention, weight loss, beta-cell function, cardiometabolic risk, diabetes-related stigma, depression, psychological support, diabetes education, technology-based interventions, clinical inertia
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Humans, Life Style, Age of Onset, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions. https://app.cochat.ai/papers/10.4093/dmj.2025.0561
- The paper
- Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025). Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2025.0561
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.